Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Jang Hyun Choi(Korea Advanced Institute of Science and Technology), Bruce M. Spiegelman(Dana-Farber Cancer Institute), Dina Laznik(Harvard University), Pontus Boström(Turku University Hospital), Jennifer L. Estall(Montreal Clinical Research Institute), Theodore M. Kamenecka(Scripps Research Institute), Michael J. Chalmers(Scripps Research Institute), Matthias Blüher(Helmholtz Centre for Environmental Research), Alexander S. Banks(Brigham and Women's Hospital), Patrick R. Griffin(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology), Shingo Kajimura(Hadassah Medical Center), Jorge L. Ruas(Karolinska Institutet)
Cited by 884
Related Papers
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|Nature Genetics|2003|10.6k
Obesity: global epidemiology and pathogenesis
|Nature Reviews Endocrinology|2019|5.1k
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
|New England Journal of Medicine|2008|2.1k
Transcriptional regulation of adipogenesis
|Genes & Development|2000|1.9k
Antioxidants prevent health-promoting effects of physical exercise in humans
|Proceedings of the National Academy of Sciences|2009|1.6k